Clinical Trial Update: Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients [NA]

View source ↗

Summary

A completed clinical trial assessed whether an angiotensin receptor antagonist can prevent cardiovascular events in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Angiotensin receptor antagonist (angiotensin II receptor blocker)

Snippet

Sponsor: Saitama Medical University | Conditions: Cardiovascular Disease | NA | Status: COMPLETED